ATE478558T1 - Antimikrobielle zusammensetzung - Google Patents

Antimikrobielle zusammensetzung

Info

Publication number
ATE478558T1
ATE478558T1 AT07759438T AT07759438T ATE478558T1 AT E478558 T1 ATE478558 T1 AT E478558T1 AT 07759438 T AT07759438 T AT 07759438T AT 07759438 T AT07759438 T AT 07759438T AT E478558 T1 ATE478558 T1 AT E478558T1
Authority
AT
Austria
Prior art keywords
antimicrobial composition
composition
antimicrobial
quinolones
antibiotic
Prior art date
Application number
AT07759438T
Other languages
English (en)
Inventor
Xintian Ming
Stephen J Rothenburger
Original Assignee
Ethicon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethicon Inc filed Critical Ethicon Inc
Application granted granted Critical
Publication of ATE478558T1 publication Critical patent/ATE478558T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/30—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests characterised by the surfactants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/44—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
    • A01N37/46—N-acyl derivatives
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/50—1,3-Diazoles; Hydrogenated 1,3-diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Dentistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT07759438T 2006-03-27 2007-03-27 Antimikrobielle zusammensetzung ATE478558T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/389,824 US8604073B2 (en) 2006-03-27 2006-03-27 Antimicrobial composition
PCT/US2007/064990 WO2007112379A2 (en) 2006-03-27 2007-03-27 Antimicrobial composition

Publications (1)

Publication Number Publication Date
ATE478558T1 true ATE478558T1 (de) 2010-09-15

Family

ID=38534247

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07759438T ATE478558T1 (de) 2006-03-27 2007-03-27 Antimikrobielle zusammensetzung

Country Status (10)

Country Link
US (1) US8604073B2 (de)
EP (1) EP1998615B1 (de)
JP (1) JP5254207B2 (de)
CN (1) CN101573031B (de)
AT (1) ATE478558T1 (de)
AU (1) AU2007230597B2 (de)
CA (1) CA2647642C (de)
DE (1) DE602007008696D1 (de)
ES (1) ES2349065T3 (de)
WO (1) WO2007112379A2 (de)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9867530B2 (en) 2006-08-14 2018-01-16 Volcano Corporation Telescopic side port catheter device with imaging system and method for accessing side branch occlusions
US9596993B2 (en) 2007-07-12 2017-03-21 Volcano Corporation Automatic calibration systems and methods of use
US10219780B2 (en) 2007-07-12 2019-03-05 Volcano Corporation OCT-IVUS catheter for concurrent luminal imaging
WO2009009799A1 (en) 2007-07-12 2009-01-15 Volcano Corporation Catheter for in vivo imaging
US20100305055A1 (en) 2007-09-13 2010-12-02 Laboratorios Miret, S.A. Combinations of polyene fungicide with cationic surfactants
US20100151104A1 (en) * 2008-10-27 2010-06-17 Pepsico, Inc. Preservative System For Beverages Based On Combinations Of Trans-Cinnamic Acid, Lauric Arginate, And Dimethyl Dicarbonate
US8808724B2 (en) * 2009-10-28 2014-08-19 Ethicon, Inc. Antimicrobial coatings with preferred microstructure for medical devices
WO2012013577A1 (en) * 2010-07-26 2012-02-02 Laboratorios Miret, S.A. Composition for coating medical devices containing lae and a polycationic amphoteric polymer
WO2012051204A2 (en) * 2010-10-11 2012-04-19 Purdue Research Foundation Antimicrobial formulations that aid in wound healing
JP2013520584A (ja) * 2010-10-14 2013-06-06 ゼウス インダストリアル プロダクツ インコーポレイテッド 抗菌基質
US11141063B2 (en) 2010-12-23 2021-10-12 Philips Image Guided Therapy Corporation Integrated system architectures and methods of use
US11040140B2 (en) 2010-12-31 2021-06-22 Philips Image Guided Therapy Corporation Deep vein thrombosis therapeutic methods
WO2013033489A1 (en) 2011-08-31 2013-03-07 Volcano Corporation Optical rotary joint and methods of use
US9292918B2 (en) 2012-10-05 2016-03-22 Volcano Corporation Methods and systems for transforming luminal images
US10568586B2 (en) 2012-10-05 2020-02-25 Volcano Corporation Systems for indicating parameters in an imaging data set and methods of use
US9367965B2 (en) 2012-10-05 2016-06-14 Volcano Corporation Systems and methods for generating images of tissue
US10070827B2 (en) 2012-10-05 2018-09-11 Volcano Corporation Automatic image playback
US9286673B2 (en) 2012-10-05 2016-03-15 Volcano Corporation Systems for correcting distortions in a medical image and methods of use thereof
US9324141B2 (en) 2012-10-05 2016-04-26 Volcano Corporation Removal of A-scan streaking artifact
US9307926B2 (en) 2012-10-05 2016-04-12 Volcano Corporation Automatic stent detection
US9858668B2 (en) 2012-10-05 2018-01-02 Volcano Corporation Guidewire artifact removal in images
US11272845B2 (en) 2012-10-05 2022-03-15 Philips Image Guided Therapy Corporation System and method for instant and automatic border detection
JP2015532536A (ja) 2012-10-05 2015-11-09 デイビッド ウェルフォード， 光を増幅するためのシステムおよび方法
US9840734B2 (en) 2012-10-22 2017-12-12 Raindance Technologies, Inc. Methods for analyzing DNA
EP2931132B1 (de) 2012-12-13 2023-07-05 Philips Image Guided Therapy Corporation Vorrichtung zur gezielten kanülierung
EP2934311B1 (de) 2012-12-20 2020-04-15 Volcano Corporation Katheter mit nahtlosem übergang
US10942022B2 (en) 2012-12-20 2021-03-09 Philips Image Guided Therapy Corporation Manual calibration of imaging system
CA2895989A1 (en) 2012-12-20 2014-07-10 Nathaniel J. Kemp Optical coherence tomography system that is reconfigurable between different imaging modes
US10939826B2 (en) 2012-12-20 2021-03-09 Philips Image Guided Therapy Corporation Aspirating and removing biological material
US11406498B2 (en) 2012-12-20 2022-08-09 Philips Image Guided Therapy Corporation Implant delivery system and implants
EP2934282B1 (de) 2012-12-20 2020-04-29 Volcano Corporation Ortung von intravaskulären bildern
JP2016501623A (ja) 2012-12-21 2016-01-21 アンドリュー ハンコック， 画像信号のマルチ経路処理のためのシステムおよび方法
US10058284B2 (en) 2012-12-21 2018-08-28 Volcano Corporation Simultaneous imaging, monitoring, and therapy
CA2895990A1 (en) 2012-12-21 2014-06-26 Jerome MAI Ultrasound imaging with variable line density
US9383263B2 (en) 2012-12-21 2016-07-05 Volcano Corporation Systems and methods for narrowing a wavelength emission of light
WO2014099763A1 (en) 2012-12-21 2014-06-26 Jason Spencer System and method for graphical processing of medical data
WO2014100162A1 (en) 2012-12-21 2014-06-26 Kemp Nathaniel J Power-efficient optical buffering using optical switch
EP2934653B1 (de) 2012-12-21 2018-09-19 Douglas Meyer Rotierender ultraschallbildgebungskatheter mit einem erweiterten katheterkörperteleskop
US9612105B2 (en) 2012-12-21 2017-04-04 Volcano Corporation Polarization sensitive optical coherence tomography system
US9486143B2 (en) 2012-12-21 2016-11-08 Volcano Corporation Intravascular forward imaging device
US10413317B2 (en) 2012-12-21 2019-09-17 Volcano Corporation System and method for catheter steering and operation
US10226597B2 (en) 2013-03-07 2019-03-12 Volcano Corporation Guidewire with centering mechanism
US9770172B2 (en) 2013-03-07 2017-09-26 Volcano Corporation Multimodal segmentation in intravascular images
EP2967391A4 (de) 2013-03-12 2016-11-02 Donna Collins Systeme und verfahren zur diagnose koronarer mikrovaskulärer erkrankungen
US20140276923A1 (en) 2013-03-12 2014-09-18 Volcano Corporation Vibrating catheter and methods of use
US9301687B2 (en) 2013-03-13 2016-04-05 Volcano Corporation System and method for OCT depth calibration
JP6339170B2 (ja) 2013-03-13 2018-06-06 ジンヒョン パーク 回転式血管内超音波装置から画像を生成するためのシステム及び方法
US11026591B2 (en) 2013-03-13 2021-06-08 Philips Image Guided Therapy Corporation Intravascular pressure sensor calibration
US10426590B2 (en) 2013-03-14 2019-10-01 Volcano Corporation Filters with echogenic characteristics
US10292677B2 (en) 2013-03-14 2019-05-21 Volcano Corporation Endoluminal filter having enhanced echogenic properties
US10219887B2 (en) 2013-03-14 2019-03-05 Volcano Corporation Filters with echogenic characteristics
EP3212204B1 (de) * 2014-10-28 2019-07-03 Biovotec AS Mikronisierte eierschalenmembranteilchen und verwendung davon zur förderung der heilung von wunden
EP3313464B1 (de) 2015-06-24 2020-08-26 Biovotec AS Gewebezüchtungsgerüste mit partikelförmiger eierschalenmembran
WO2017007776A1 (en) * 2015-07-06 2017-01-12 Archangel, Llc Method and system for treatment of microorganisms during propagation, conditioning, fermentation, and preservation using lae and selected additives
GB201519923D0 (en) 2015-11-11 2015-12-23 Biovotec Dac And Biovotec As Dry biocompatible disintegrateable films for delivering particulate egg shell membrane to a wound
WO2018201119A1 (en) 2017-04-29 2018-11-01 Nevada Naturals Inc. Biofilm penetrating compositions and methods
US11840499B2 (en) * 2020-02-28 2023-12-12 The United States Of America, As Represented By The Secretary Of Agriculture Biobased-fatty acid arginates
KR102350121B1 (ko) * 2020-08-10 2022-01-12 건국대학교 산학협력단 항생제 내성 황색포도상구균 억제용 항균 조성물
KR20240036492A (ko) 2021-01-27 2024-03-20 펩토닉 메디컬 에이비 생물막 분해 또는 생물막 형성 방지에 사용하기 위한 조성물

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3069320A (en) * 1958-11-18 1962-12-18 American Cyanamid Co Synergistic sanitizing process with neomycin and selected cationic surface active quaternary ammonium salts
US3839297A (en) * 1971-11-22 1974-10-01 Ethicon Inc Use of stannous octoate catalyst in the manufacture of l(-)lactide-glycolide copolymer sutures
US4027676A (en) * 1975-01-07 1977-06-07 Ethicon, Inc. Coated sutures
JPS5283942A (en) * 1976-01-01 1977-07-13 Ajinomoto Co Inc Medicine for superficial infection through skin
US4201216A (en) * 1976-12-15 1980-05-06 Ethicon, Inc. Absorbable coating composition for sutures
US4185637A (en) * 1978-05-30 1980-01-29 Ethicon, Inc. Coating composition for sutures
JPS59212405A (ja) 1983-05-18 1984-12-01 Lion Corp 防かび剤組成物
DK154806C (da) 1986-12-19 1989-06-26 Coloplast As Saarplejemiddel indeholdende et aktivt stof til fremme af saarbehandlingen og fremgangsmaade til fremstilling deraf
WO1992018098A1 (en) * 1991-04-10 1992-10-29 Capelli Christopher C Antimicrobial compositions useful for medical applications
WO1994019027A1 (en) 1993-02-26 1994-09-01 Wesley-Jessen Corporation Method and composition for disinfecting contact lenses
US5869073A (en) * 1993-12-20 1999-02-09 Biopolymerix, Inc Antimicrobial liquid compositions and methods for using them
JP3637617B2 (ja) * 1994-12-28 2005-04-13 味の素株式会社 殺菌消毒用組成物
JPH10183705A (ja) 1996-11-07 1998-07-14 Noriatsu Kojima 排水用集合管継手
AU5153399A (en) * 1998-08-14 2000-03-06 Coloplast A/S Stabilised compositions having antibacterial activity
KR100411178B1 (ko) 2000-10-09 2003-12-18 한국화학연구원 신규 항균제와 이러한 항균제를 함유하는 항균탈취성 용액
US7758851B2 (en) 2001-08-09 2010-07-20 Laboratorios Miret, S.A. Preservative systems and their use in cosmetic preparations
US6767551B2 (en) * 2001-08-15 2004-07-27 Sherwood Services Ag Coating for use with medical devices and method of making same
EP2082724B1 (de) * 2001-11-15 2013-08-21 Laboratorios Miret, S.A. Verwendung eines kationischen Tensids als Aktivitätsverstärker bei Deodorants und der Mundpflege
US20050192547A1 (en) * 2002-01-31 2005-09-01 Modak Shanta M. Combinations of antiseptic and antibiotic agents containing medical devices
US20060177548A1 (en) 2005-02-08 2006-08-10 Unilever Bestfoods, North America Preservative system
US20060263444A1 (en) 2005-05-19 2006-11-23 Xintian Ming Antimicrobial composition
US20060264347A1 (en) 2005-05-19 2006-11-23 Xintian Ming Antimicrobial composition
AU2006294652A1 (en) * 2005-09-28 2007-04-05 University Of Massachusetts Stabilized antimicrobial compositions and related methods of preparation

Also Published As

Publication number Publication date
JP5254207B2 (ja) 2013-08-07
CN101573031A (zh) 2009-11-04
DE602007008696D1 (de) 2010-10-07
EP1998615B1 (de) 2010-08-25
ES2349065T3 (es) 2010-12-22
US20070225220A1 (en) 2007-09-27
WO2007112379A3 (en) 2008-12-18
WO2007112379A2 (en) 2007-10-04
CA2647642A1 (en) 2007-10-04
AU2007230597B2 (en) 2012-04-26
AU2007230597A1 (en) 2007-10-04
US8604073B2 (en) 2013-12-10
CA2647642C (en) 2014-10-07
EP1998615A2 (de) 2008-12-10
CN101573031B (zh) 2013-11-20
JP2009531458A (ja) 2009-09-03

Similar Documents

Publication Publication Date Title
ATE478558T1 (de) Antimikrobielle zusammensetzung
WO2006125099A3 (en) Antimicrobial composition
WO2006125121A3 (en) Antimicrobial composition comprising a cationic surfacant and an iodinated sulpone compound
CL2008003406A1 (es) Compuestos derivados de quinolina; composicion farmaceutica que los comprende; y uso en el tratamiento de una infeccion por vih.
MX338505B (es) Combinaciones utiles de antibioticos de monobactama con inhibidores de beta-lactamasa.
BRPI0916515B8 (pt) polipeptídeo de fator estimulante de colônias de granulócitos bovino (bg-csf), formulação farmacêutica e composição compreendendo o mesmo
CL2011000729A1 (es) Compuestos derivados de metanopirazolo[3,4-e][1,3]diazepin; procedimiento de preparacion; composicion farmaceutica que los comprende; y su uso en el tratamiento de infecciones bacterianas.
EP2062581A4 (de) Antibiotische zusammensetzung mit beta-lactam-antibiotika und ionischen chelatbildnern
EA201000775A1 (ru) Ингибиторы бета-лактамазы
MX2010002930A (es) Formulaciones que comprenden una composicion anti-microbiana.
NO20025954D0 (no) Glykopeptidfosfonatderivater
WO2014028931A3 (en) Compounds and methods for treating mammalian gastrointestinal microbial infections
EP2348039A3 (de) Zyklische antimikrobielle Peptide
WO2006081289A3 (en) Antibacterial agents
DK1901723T3 (da) Antimikrobielle materialer
CL2009002129A1 (es) Derivados carboxiamida de lantibioticos; proceso de preparacion de dichos lantibioticos; composicion farmaceutica que lo contiene; utiles en el tratamiento de infecciones bacterianas.
HK1116482A1 (en) Oxazolidinone derivatives and use thereof as antibiotics
BR112013004436A2 (pt) composições e usos de materiais com atividade microbicida alta e toxicidade baixa
CL2007003693A1 (es) Compuestos derivados de pirido [3,2-b] [1,4] tiazina; composicion farmaceutica que contiene dichos compuestos; y su uso en el tratamiento de infecciones bacterianas.
CL2012001757A1 (es) Compuestos derivados de 8-hidroxiquinolina-7-carboxamida; composicion farmaceutica; y su uso en el tratamiento de infecciones micoticas.
MX2009012370A (es) Formulacion de antraciclina de baja viscosidad.
WO2009120389A8 (en) Oral and injectable formulations of tetracycline compounds
CL2004001012A1 (es) Compuestos derivados de macrolidos de 14 o 15 miembros, sustituidos en posicion 4"; procedimiento para su preparacion; composicion farmaceutica que lo comprende; y su uso para el tratamiento o profilaxis de infecciones microbianas sistemicas o topica
BRPI0810192A2 (pt) Aspartato do ácido 1-ciclopropil-6-fluoro-7-(8-metoxiimino-2,6-diazaespir o [3,4] oct-6-il)-4-oxo-1,4-diidro- [1,8] naftiridina-3-carboxílico, método para preparação do mesmo e composição farmacêutica antimicrobiana compreendendo o mesmo.
WO2008026075A3 (en) Treatment of intracellular bacterial infections with a protein kinase inhibitor or an as160 polypeptide activator

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties